Digital PCR Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Digital PCR Market by application (Clinical Diagnostics, and Forensic, Research, & Others), by Technologies (Chip Based Digital PCR, Droplet Digital PCR, and Beaming Digital PCR), Product Type (Software & Services, Digital PCR Systems, Consumables & Reagents), and End User (Clinical Diagnostic Laboratories, Pharmaceuticals & Biotechnology Industries, and Universities & Other Organizations) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

The digital PCR market is valued at USD 506.42 million in 2021 and is poised to grow at a significant CAGR of 9.2% over 2022–2028. Digital PCR (dPCR) is a newer PCR technology that has been used in molecular genetic analysis for the detection of cancer, mutational analysis, quantitative gene expression study, and evaluation of allelic imbalance. There is an urgent need to adopt cutting-edge diagnostic tools and therapies to help reduce the disease burden due to the rising incidence of infectious diseases and cancer around the world and the rise of rare cancer incidences. Due to the utilization of their novel applications in laboratories, it is anticipated that the global digital polymerase chain reaction market would experience a significant amount of opportunistic emphasis. In the continents of Asia and Africa, a surge in the demand for digital PCR from veterinary and medical microbiology is expected to fuel the market revenue over the forecast period. Furthermore, due to its higher efficacy and simplicity of use, clinical diagnostic applications of digital PCR are only anticipated to present an adaptive approach during the forecast period, propelling market expansion. New plant species identification, veterinary illness diagnostics, and animal species identification also use portable digital PCR. Therefore, a sizable pool of consumers is anticipated to be drawn to the plethora of applications of digital PCR in domains such as healthcare, food, environment, animal health, conservation, and forensics, aside from the detection of diseases. Additionally, it is projected that improvements in digital PCR technology and an increase in product launches on the worldwide market would support the development of the digital PCR business. For instance, one of the world’s top companies in the life sciences sector, Bio-Rad Laboratories, Inc., announced the release of the prevalence dPCR SARS-CoV-2 wastewater quantification kit for COVID-19 wastewater testing in June 2021. Additionally, the expansion of collaboration agreements between businesses for the development of digital PCR and the surge in R&D activity for PCR technology advancement both contribute to the growth of the digital PCR industry. As an illustration, in January 2022, Qiagen, a well-known manufacturer of diagnostic tools, collaborated with Atila BioSystems and Actome GmbH to offer non-invasive prenatal testing (NIPT) options for QIAGEN’s dPCR and license & co-marketing agreement.

Recent Market Developments:

In February 2022, F. Hoffmann-La Roche Ltd expanded the COVID-19 PCR tests in countries accepting the CE market.

In 2020, Bio-Rad received FDA emergency use authorization for the Droplet Digital PCR SARS-CoV-2 Test Kit.

In 2020, bioMérieux S.A. received the CE Mark approval for SARS-CoV-2 R-GENE tests to include saliva specimens. The company also received emergency use authorization for the BioFire COVID-19 test.

Digital PCR Market

MARKET SUMMARY
-
9.2%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 9.2%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Digital PCR Market

  • The report on global digital PCR market gives historical, current, and future market sizes (US$ Bn) on the basis of product, application, technology, end user and geography.
  • The global digital PCR market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Leaders
  • F. Hoffmann-la Roche ltd.
  • Agilent technologies, Inc.
  • Promega corporation
  • Abbott laboratories
  • Biomerieux SA
  • Merck KGaA
Digital PCR Market

Drivers and Restraints

The pace of R&D into novel genetic technologies and product development has accelerated the growing consumer demand for early disease detection and treatment. A rise in investments and the availability of money and grants have contributed to this increase in R&D activity. Additionally, governmental and federal organizations increasingly appreciate digital PCR products worldwide for their use in genomics-based research. Over the last ten years, the digital PCR sector has seen several financing initiatives by public and private organizations to assist genomic analysis. However, the market is limited by the high cost of dPCR instruments and problems with reimbursement for such devices.


Digital PCR Market Regional Analysis

North America dominates the market

The digital PCR market in North America is likely to hold a significant revenue share in 2021, it is predicted to expand at significant CAGR over the forecast period. The adoption of cutting-edge and unique genomic analysis products, including advanced dPCR market products, is primarily responsible for the growth of the North American dPCR Market. The development of the dPCR market in North America is driven by the expansion of R&D funding opportunities for genomic research and the region's robust research infrastructure. While the dPCR Market is expected to experience growth in the Asia Pacific region due to the region's rapidly developing economies, increased government support for life science research, aging populations linked to an increase in the incidence of genetic diseases, expanding research, and clinical trial outsourcing from the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Digital PCR Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Digital PCR Market is projected to expand at a CAGR of 9.2% during the forecast period.

Agilent technologies, Inc., Promega corporation, Abbott laboratories, Biomerieux SA, Merck KGaA

Asia Pacific is the fastest-growing region for Digital PCR Market


Report

Table Of Content


Report

Company Profile

  • QIAGEN
  • Takara bio, Inc.
  • F. Hoffmann-la Roche ltd.
  • Agilent technologies, Inc.
  • Promega corporation
  • Abbott laboratories
  • Biomerieux SA

Description

The digital PCR market is valued at USD 506.42 million in 2021 and is poised to grow at a significant CAGR of 9.2% over 2022–2028. Digital PCR (dPCR) is a newer PCR technology that has been used in molecular genetic analysis for the detection of cancer, mutational analysis, quantitative gene expression study, and evaluation of allelic imbalance. There is an urgent need to adopt cutting-edge diagnostic tools and therapies to help reduce the disease burden due to the rising incidence of infectious diseases and cancer around the world and the rise of rare cancer incidences. Due to the utilization of their novel applications in laboratories, it is anticipated that the global digital polymerase chain reaction market would experience a significant amount of opportunistic emphasis. In the continents of Asia and Africa, a surge in the demand for digital PCR from veterinary and medical microbiology is expected to fuel the market revenue over the forecast period. Furthermore, due to its higher efficacy and simplicity of use, clinical diagnostic applications of digital PCR are only anticipated to present an adaptive approach during the forecast period, propelling market expansion. New plant species identification, veterinary illness diagnostics, and animal species identification also use portable digital PCR. Therefore, a sizable pool of consumers is anticipated to be drawn to the plethora of applications of digital PCR in domains such as healthcare, food, environment, animal health, conservation, and forensics, aside from the detection of diseases. Additionally, it is projected that improvements in digital PCR technology and an increase in product launches on the worldwide market would support the development of the digital PCR business. For instance, one of the world’s top companies in the life sciences sector, Bio-Rad Laboratories, Inc., announced the release of the prevalence dPCR SARS-CoV-2 wastewater quantification kit for COVID-19 wastewater testing in June 2021. Additionally, the expansion of collaboration agreements between businesses for the development of digital PCR and the surge in R&D activity for PCR technology advancement both contribute to the growth of the digital PCR industry. As an illustration, in January 2022, Qiagen, a well-known manufacturer of diagnostic tools, collaborated with Atila BioSystems and Actome GmbH to offer non-invasive prenatal testing (NIPT) options for QIAGEN’s dPCR and license & co-marketing agreement.

Recent Market Developments:

In February 2022, F. Hoffmann-La Roche Ltd expanded the COVID-19 PCR tests in countries accepting the CE market.

In 2020, Bio-Rad received FDA emergency use authorization for the Droplet Digital PCR SARS-CoV-2 Test Kit.

In 2020, bioMérieux S.A. received the CE Mark approval for SARS-CoV-2 R-GENE tests to include saliva specimens. The company also received emergency use authorization for the BioFire COVID-19 test.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX